ArticleThe Journal of dermatology2026

Real-World Experience With Single Ultra-Low Dose Rituximab for Remission Induction in Pemphigus.

Yu-Chen Jeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.